Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04234061
What this trial is testing

Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma Recurrent
Peter MacCallum Cancer Centre, Australia 20
Testing effectiveness (Phase 2)Ended earlyNCT03758417
What this trial is testing

LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nanjing Legend Biotech Co. 123
Not applicableLooking for participantsNCT07075523
What this trial is testing

Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy

Who this might be right for
CAR T-Cell Therapy
University of California, San Diego 36
Early research (Phase 1)Active Not RecruitingNCT03620058
What this trial is testing

CART22 Alone or in Combination With huCART19 for ALL

Who this might be right for
Chemotherapy Resistant Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia
University of Pennsylvania 23
Very early researchUnknownNCT05085418
What this trial is testing

CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis

Who this might be right for
Immune NephritisAutoimmune DiseasesLupus Nephritis
Zhejiang University 9
Not applicableUnknownNCT03624686
What this trial is testing

Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies

Who this might be right for
Leukemia
National Taiwan University Hospital 130
Early research (Phase 1)Looking for participantsNCT07250386
What this trial is testing

CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Early research (Phase 1)Study completedNCT03980288
What this trial is testing

4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3

Who this might be right for
Advanced Hepatocellular Carcinoma
Zhejiang University 6
Testing effectiveness (Phase 2)WithdrawnNCT02575261
What this trial is testing

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

Who this might be right for
EphA2 Positive Malignant GliomaCAR-T Cell Immunotherapy
Fuda Cancer Hospital, Guangzhou
Early research (Phase 1)Study completedNCT01087294
What this trial is testing

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, B-cellLymphoma, HodgkinsLymphoma, Non-hodgkins+1 more
National Cancer Institute (NCI) 85
Early research (Phase 1)Active Not RecruitingNCT04214886
What this trial is testing

CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, AdultB-cell Lymphoma RefractoryB-cell Lymphoma Recurrent
Loyola University 24
Early research (Phase 1)Looking for participantsNCT05631886
What this trial is testing

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Who this might be right for
Solid Tumor, AdultLymphomaEphA2 Overexpression+4 more
Chinese PLA General Hospital 10
Not applicableUnknownNCT04151186
What this trial is testing

A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors

Who this might be right for
Advanced Solid TumorNeoplasms
suhaichuan 72
Testing effectiveness (Phase 2)Study completedNCT03076437
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaLymphoma
Shenzhen Institute for Innovation and Translational Medicine 28
Testing effectiveness (Phase 2)Looking for participantsNCT07575919
What this trial is testing

Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Liping Dou 20
Early research (Phase 1)Temporarily pausedNCT03710421
What this trial is testing

CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05934448
What this trial is testing

Pembro Plus CAR T-cell Therapy in R/R in PMBCL

Who this might be right for
Primary Mediastinal Large B-cell Lymphoma (PMBCL)Primary Mediastinal Large B Cell LymphomaPrimary Mediastinal Large B-Cell Lymphoma Refractory+3 more
Jennifer Crombie, MD 35
Testing effectiveness (Phase 2)UnknownNCT04846439
What this trial is testing

Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL

Who this might be right for
Platelet Transfusion RefractorinessAcute Leukemia in Remission
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Looking for participantsNCT05043571
What this trial is testing

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LeukemiaLymphoblastic Leukemia, Acute Adult+4 more
National University Hospital, Singapore 20
Early research (Phase 1)Looking for participantsNCT06626919
What this trial is testing

Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Who this might be right for
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Arcellx, Inc. 30
Next Page